Online Only Articles

ARID1A mutation in blastic plasmacytoid dendritic cell neoplasm

Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China;Institute of Hematology, Zhejiang University, Hangzhou, China;Key Laboratory of Hematologic Malignancies, Diagnosis and Treatment, Zhejiang, Hangzhou, China
Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China;Institute of Hematology, Zhejiang University, Hangzhou, China;Key Laboratory of Hematologic Malignancies, Diagnosis and Treatment, Zhejiang, Hangzhou, China
Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China;Institute of Hematology, Zhejiang University, Hangzhou, China;Key Laboratory of Hematologic Malignancies, Diagnosis and Treatment, Zhejiang, Hangzhou, China
Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China;Institute of Hematology, Zhejiang University, Hangzhou, China;Key Laboratory of Hematologic Malignancies, Diagnosis and Treatment, Zhejiang, Hangzhou, China
Institute of Hematology, Zhejiang University, Hangzhou, China;Key Laboratory of Hematologic Malignancies, Diagnosis and Treatment, Zhejiang, Hangzhou, China
Department of Pathology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China
Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China;Institute of Hematology, Zhejiang University, Hangzhou, China;Key Laboratory of Hematologic Malignancies, Diagnosis and Treatment, Zhejiang, Hangzhou, China
Vol. 102 No. 11 (2017): November, 2017 https://doi.org/10.3324/haematol.2017.172742